Introduction
MRSA infection is a major health care problem. In 2008, as a component of a general strategy for infection prevention, a program to control MRSA was implemented in our ICU, consisting in pre-emptive isolation, rapid screening tests for identification of MRSA carriers and targeted decolonization with nasal mupirocin in addition to antiseptic body bathing. At the same time, screening of at-risk patients along with targeted isolation and antiseptic body washing was implemented in general wards.
Objectives
To evaluate the compliance with this strategy and the success of nasal eradication. To assess MRSA colonization prevalence and transmission rate evolution. To analyse this strategy impact on MRSA rates, oxacillin-resistance and anti-MRSA antibiotic consumption.
Methods
We retrospectively analyzed all patients admitted to our ICU between 2010 and 2014. Data collected included demographics, nasal swab, isolation measures and nasal mupirocin prescription, staphylococcus aureus isolates and pattern of sensibility along with consumption of vancomycin, linezolid, tigecycline and daptomycin.
Results 1753 admissions and 3149 nasal swabs were analyzed during the study period. On admission 98% (1720/1753) of patients had a nasal swab taken. We found a documented order for contact isolation in 92,5% of the positive (colonized) patients. 
Conclusions
MRSA incidence and methicillin resistance is decreasing in our ICU and this may be related to our strategy to control MRSA along with a multidirectional infection prevention approach. The declining in consumption of anti-MRSA antibiotics may reflect not only a reduction in clinical infections but also less MRSA coverage in the empirical treatment of nosocomial infections. The compliance with the strategy has improved but the nasal eradication rate remains low. Transmission rate of MRSA remains higher than expected, signaling that more efforts must be done in enhancing transversal infection prevention measures.
